Valuation: Camurus AB

Market Cap 38.26B 3.82B 3.41B 3.18B 2.89B 5.45B 370B 5.49B 14.95B 188B 14.34B 14.03B 604B P/E 2026 *
39.2x
P/E 2027 * 27.2x
Enterprise Value 33.74B 3.37B 3.01B 2.81B 2.55B 4.8B 326B 4.84B 13.18B 166B 12.64B 12.37B 533B EV / Sales 2026 *
11.7x
EV / Sales 2027 * 8.77x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+0.94%
1 week+2.96%
Current month+2.96%
1 month+11.05%
3 months+11.25%
6 months+36.23%
Current year+4.38%
1 week 608
Extreme 608
668.5
1 month 573.5
Extreme 573.5
668.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
710
3 years 304.2
Extreme 304.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Sell

Executive/Senior Manager

-5,800 0.0096%
2/27/26 Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+0.94%+2.96%-5.65%+111.10% 3.8B
+2.70%+2.73%+40.91%+110.31% 1,032B
+1.44%-2.38%+36.83%+63.95% 614B
+1.75%+3.73%+16.55%+83.05% 471B
+0.60%-1.73%+62.98%+37.46% 350B
+2.92%+3.06%+24.83%+45.10% 337B
+2.42%-0.74%+13.44%+35.80% 268B
+1.86%-0.81%-4.69%+12.20% 246B
+2.60%-2.00%+39.77%+54.44% 218B
+1.82%-1.48%+25.75%+96.48% 179B
Average +1.41%-2.86%+25.07%+64.99% 371.86B
Weighted average by Cap. +0.81%-3.18%+31.92%+70.63%

Financials

2026 *2027 *
Net sales 2.88B 288M 257M 240M 218M 410M 27.85B 414M 1.13B 14.16B 1.08B 1.06B 45.53B 3.7B 370M 330M 308M 280M 527M 35.77B 531M 1.45B 18.19B 1.39B 1.36B 58.48B
Net income 979M 97.68M 87.28M 81.43M 73.96M 139M 9.45B 140M 382M 4.81B 367M 359M 15.45B 1.41B 141M 126M 117M 106M 200M 13.6B 202M 550M 6.92B 528M 516M 22.23B
Net Debt -4.53B -452M -404M -377M -342M -644M -43.71B -649M -1.77B -22.23B -1.7B -1.66B -71.46B -5.76B -575M -514M -480M -436M -820M -55.65B -827M -2.25B -28.3B -2.16B -2.11B -90.99B
Projected Income Statement - Annual - Camurus AB
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
26-10-07 SEK 643.00 +0.94% 91,988
26-10-06 SEK 637.00 +0.71% 234,978
26-10-05 SEK 632.50 +4.03% 151,374
26-10-02 SEK 608.00 -2.49% 71,387
26-10-01 SEK 623.50 -0.16% 76,356
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Camurus AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
643.00SEK
Average target price
797.50SEK
Spread / Average Target
+24.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camurus AB
  1. Stock Market
  2. Stocks
  3. CAMX Stock